Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt, MD, Samuel R. Money, MD, Eric P. Brass, MD, PhD Journal of Vascular Surgery Volume 47, Issue 2, Pages 330-336.e2 (February 2008) DOI: 10.1016/j.jvs.2007.10.009 Copyright © 2008 The Society for Vascular Surgery Terms and Conditions
Fig All cause mortality ≤30 days after the last dose of drug in the on-treatment population. Journal of Vascular Surgery 2008 47, 330-336.e2DOI: (10.1016/j.jvs.2007.10.009) Copyright © 2008 The Society for Vascular Surgery Terms and Conditions